Bio-Industry Committee

The Bio-Industry Committee is responsible for providing input on biotechnology industry trends affecting the gene therapy sector, such as manufacturing, investment, and market trends. The duties of the committee include recommending sessions relevant to the industry and the Society for the Annual Meeting, and serving as a networking resource to Society members from industry.
Full NamePositionOrganizationTerm StartTerm End
Kate J. Excoffon, PhDChairGene Tx Optmized6/1/20255/31/2027421
Karen MaloneMemberGeneScape6/1/20255/31/202873864
Devarshi KapadiaMemberLonza6/1/20245/31/202757062
Teilo SchallerMemberSiren Biotechnology6/1/20245/31/202753786
Susumu Uchiyama, PhDMemberOsaka University6/1/20245/31/202748930
Patrick L. Sinn, PhDMemberUniversity of Iowa6/1/20265/31/20294051
Safi ShahdaMemberIntellia Therapeutics6/1/20255/31/202858186
Nadia SellamiMemberPacBio6/1/20245/31/202767782
Daniel G. Kavanagh, PhD, RACMemberWCG6/1/20255/31/202824630
Catherine Argyriou, BS, MS, PhDMemberChildren's Hospital Los Angeles / University of Southern California6/1/20265/31/202929258
Huiya Yang, PhDMemberPrime Medicine6/1/20255/31/202868050
Paola Leone, PhDMemberROWAN -VIRTUA School of Osteopathic Medicine6/1/20265/31/2029848
Shana H. Thomas, PhDMemberKite Pharma, a Gilead Company6/1/20235/31/202961110
Vivian ZhangMemberMinaris Advanced Therapy6/1/20255/31/202869810
Stephen M. KaminskyMemberWeill Cornell Medical College6/1/20265/31/2029727
Waleed Abubaker Abdelgalil Abdelmaguid, PhDMemberNationwide Children's Hospital6/1/20235/31/202958511